Alternative splicing and disease.

[1]  J. Tazi,et al.  A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects , 2008, Human mutation.

[2]  T. Glisovic,et al.  RNA‐binding proteins and post‐transcriptional gene regulation , 2008, FEBS letters.

[3]  S. Stamm,et al.  Substances that can change alternative splice-site selection. , 2008, Biochemical Society transactions.

[4]  Marwan Shinawi,et al.  Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster , 2008, Nature Genetics.

[5]  Lili Wan,et al.  SMN Deficiency Causes Tissue-Specific Perturbations in the Repertoire of snRNAs and Widespread Defects in Splicing , 2008, Cell.

[6]  B. Wirth,et al.  Plastin 3 Is a Protective Modifier of Autosomal Recessive Spinal Muscular Atrophy , 2008, Science.

[7]  D. Hunt,et al.  Disease mechanism for retinitis pigmentosa (RP11) caused by missense mutations in the splicing factor gene PRPF31 , 2008, Molecular vision.

[8]  G. van Ommen,et al.  The therapeutic potential of antisense-mediated exon skipping. , 2008, Current opinion in molecular therapeutics.

[9]  P. Iversen,et al.  Arginine‐rich cell penetrating peptides: Design, structure–activity, and applications to alter pre‐mRNA splicing by steric‐block oligonucleotides , 2008, Journal of peptide science : an official publication of the European Peptide Society.

[10]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[11]  Tom Misteli,et al.  TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression , 2008, Proceedings of the National Academy of Sciences.

[12]  U. Francke,et al.  SnoRNA Snord116 (Pwcr1/MBII-85) Deletion Causes Growth Deficiency and Hyperphagia in Mice , 2008, PloS one.

[13]  K. Lynch,et al.  Regulation of Alternative Splicing: More than Just the ABCs* , 2008, Journal of Biological Chemistry.

[14]  Britta Hartmann,et al.  Genome-wide Analysis of Alternative Pre-mRNA Splicing* , 2008, Journal of Biological Chemistry.

[15]  K. J. Hertel,et al.  Combinatorial Control of Exon Recognition* , 2008, Journal of Biological Chemistry.

[16]  Stefan Stamm,et al.  Regulation of Alternative Splicing by Reversible Protein Phosphorylation* , 2008, Journal of Biological Chemistry.

[17]  G. Ast,et al.  Alternative splicing: current perspectives , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[18]  Gil Ast,et al.  Alternative splicing and disease , 2008, RNA biology.

[19]  Leonardo Fazio,et al.  Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory , 2007, Proceedings of the National Academy of Sciences.

[20]  J. Manley,et al.  hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing. , 2007, Human molecular genetics.

[21]  V. Beneš,et al.  Diverse roles of hnRNP L in mammalian mRNA processing: a combined microarray and RNAi analysis. , 2007, RNA.

[22]  D. Bennett,et al.  Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. , 2007, Human molecular genetics.

[23]  J. Brosius,et al.  Deletion of the MBII-85 snoRNA Gene Cluster in Mice Results in Postnatal Growth Retardation , 2007, PLoS genetics.

[24]  J. Manley,et al.  Protein-free spliceosomal snRNAs catalyze a reaction that resembles the first step of splicing. , 2007, RNA.

[25]  Adi Doron-Faigenboim,et al.  The “Alternative” Choice of Constitutive Exons throughout Evolution , 2007, PLoS genetics.

[26]  J. Beggs,et al.  prp8 mutations that cause human retinitis pigmentosa lead to a U5 snRNP maturation defect in yeast , 2007, Nature Structural &Molecular Biology.

[27]  Rolf Backofen,et al.  Pre-mRNA Secondary Structures Influence Exon Recognition , 2007, PLoS genetics.

[28]  D. A. Stein,et al.  Cell penetrating peptide conjugates of steric block oligonucleotides☆ , 2007, Advanced Drug Delivery Reviews.

[29]  Guey-Shin Wang,et al.  Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. , 2007, Molecular cell.

[30]  G. van Ommen,et al.  Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications. , 2007, RNA.

[31]  J. Tazi,et al.  Small-Molecule Inhibition of HIV pre-mRNA Splicing as a Novel Antiretroviral Therapy to Overcome Drug Resistance , 2007, PLoS pathogens.

[32]  L. Petrucelli,et al.  Progranulin Mediates Caspase-Dependent Cleavage of TAR DNA Binding Protein-43 , 2007, The Journal of Neuroscience.

[33]  G. Ast,et al.  IKAP/hELP1 deficiency in the cerebrum of familial dysautonomia patients results in down regulation of genes involved in oligodendrocyte differentiation and in myelination. , 2007, Human molecular genetics.

[34]  M. Vitek,et al.  The Tau N279K Exon 10 Splicing Mutation Recapitulates Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 Tauopathy in a Mouse Model , 2007, The Journal of Neuroscience.

[35]  I. Lemm,et al.  Involvement of Nuclear Import and Export Factors in U8 Box C/D snoRNP Biogenesis , 2007, Molecular and Cellular Biology.

[36]  L. Cupples,et al.  A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol. , 2007, Human molecular genetics.

[37]  R. Skotheim,et al.  Alternative splicing in cancer: noise, functional, or systematic? , 2007, The international journal of biochemistry & cell biology.

[38]  A. Krainer,et al.  Alternative splicing regulation by interaction of phosphatase PP2Cγ with nucleic acid–binding protein YB-1 , 2007, Nature Structural &Molecular Biology.

[39]  T. Samuelsson,et al.  Useful ‘junk’: Alu RNAs in the human transcriptome , 2007, Cellular and Molecular Life Sciences.

[40]  W. Noble,et al.  Biomedicine & Diseases: Review RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies , 2007 .

[41]  Ping Li,et al.  Binding of the Human Prp31 Nop Domain to a Composite RNA-Protein Platform in U4 snRNP , 2007, Science.

[42]  K. Jiang,et al.  Ceramide-activated protein phosphatase involvement in insulin resistance via Akt, serine/arginine-rich protein 40, and ribonucleic acid splicing in L6 skeletal muscle cells. , 2007, Endocrinology.

[43]  A. Krainer,et al.  The gene encoding the splicing factor SF2/ASF is a proto-oncogene , 2007, Nature Structural &Molecular Biology.

[44]  L. D. Schroeder,et al.  Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer. , 2007, American journal of human genetics.

[45]  J. Valcárcel,et al.  Fas-activated Serine/Threonine Kinase (FAST K) Synergizes with TIA-1/TIAR Proteins to Regulate Fas Alternative Splicing* , 2007, Journal of Biological Chemistry.

[46]  R. Ljung,et al.  The thalassaemia syndromes , 2007, Scandinavian journal of clinical and laboratory investigation.

[47]  C. Burge,et al.  Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia , 2007, Human mutation.

[48]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[49]  J. Manley,et al.  PP1/PP2A phosphatases are required for the second step of Pre-mRNA splicing and target specific snRNP proteins. , 2006, Molecular cell.

[50]  E. Buratti,et al.  Defective splicing, disease and therapy: searching for master checkpoints in exon definition , 2006, Nucleic acids research.

[51]  M. Stoler,et al.  cis-requirement for the maintenance of round spermatid-specific transcription. , 2006, Developmental biology.

[52]  B. Blencowe.  Alternative Splicing: New Insights from Global Analyses , 2006, Cell.

[53]  Michael R. Green,et al.  RS domains contact splicing signals and promote splicing by a common mechanism in yeast through humans. , 2006, Genes & development.

[54]  J. Growdon,et al.  No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer’s disease brain , 2006, Acta Neuropathologica.

[55]  A Keith Dunker,et al.  Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[56]  H. Stark,et al.  Cryo-electron microscopy of spliceosomal components. , 2006, Annual review of biophysics and biomolecular structure.

[57]  J. Venables.  Unbalanced alternative splicing and its significance in cancer , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[58]  K. Jellinger,et al.  The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2‐BETA1 changes in sporadic Alzheimer's disease , 2006, Journal of neurochemistry.

[59]  B. Frey,et al.  Quantitative microarray profiling provides evidence against widespread coupling of alternative splicing with nonsense-mediated mRNA decay to control gene expression. , 2006, Genes & development.

[60]  S. Stamm,et al.  The snoRNA HBII-52 Regulates Alternative Splicing of the Serotonin Receptor 2C , 2006, Science.

[61]  Masatoshi Hagiwara,et al.  Alternative splicing: a new drug target of the post-genome era. , 2005, Biochimica et biophysica acta.

[62]  Michael R Green,et al.  Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. , 2005, Molecular cell.

[63]  P. Stenson,et al.  The Human Gene Mutation Database (HGMD) and Its Exploitation in the Study of Mutational Mechanisms , 2005, Current protocols in bioinformatics.

[64]  Albrecht Bindereif,et al.  Alternative pre-mRNA splicing in the human system: unexpected role of repetitive sequences as regulatory elements , 2005, Biological chemistry.

[65]  F. Végran,et al.  Distinct expression of Survivin splice variants in breast carcinomas. , 2005, International journal of oncology.

[66]  M. Moore.  From Birth to Death: The Complex Lives of Eukaryotic mRNAs , 2005, Science.

[67]  S. Salzberg,et al.  The Transcriptional Landscape of the Mammalian Genome , 2005, Science.

[68]  P. Lantos,et al.  Quantitative analysis of tau isoform transcripts in sporadic tauopathies. , 2005, Brain research. Molecular brain research.

[69]  G. Helt,et al.  Transcriptional Maps of 10 Human Chromosomes at 5-Nucleotide Resolution , 2005, Science.

[70]  S. Pantano,et al.  Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function. , 2005, Journal of molecular biology.

[71]  T. Misteli,et al.  Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome , 2005, Nature Medicine.

[72]  S. Stamm,et al.  Function of Alternative Splicing , 2004 .

[73]  A. Andreadis.  Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. , 2005, Biochimica et biophysica acta.

[74]  E. Buratti,et al.  Influence of RNA Secondary Structure on the Pre-mRNA Splicing Process , 2004, Molecular and Cellular Biology.

[75]  L. Dwyer-Nield,et al.  Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: Implications for pre‐mRNA processing , 2004, Molecular carcinogenesis.

[76]  R. Kole,et al.  Antisense derivatives of U7 and other small nuclear RNAs as tools to modify pre-mRNA splicing patterns , 2004 .

[77]  W. Jin,et al.  Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements. , 2004, Human molecular genetics.

[78]  J. Brion,et al.  Expression of tau mRNA and soluble tau isoforms in affected and non‐affected brain areas in Alzheimer's disease , 2004, FEBS letters.

[79]  C. Shin,et al.  Cell signalling and the control of pre-mRNA splicing , 2004, Nature Reviews Molecular Cell Biology.

[80]  E. Androphy,et al.  In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes. , 2004, RNA.

[81]  Tadashi Kondo,et al.  Alternative splice variant of actinin-4 in small cell lung cancer , 2004, Oncogene.

[82]  J. Steitz,et al.  A molecular link between SR protein dephosphorylation and mRNA export. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[83]  Dirk G Kieback,et al.  Expression of splicing factors in human ovarian cancer. , 2004, Oncology reports.

[84]  Gil Ast,et al.  Comparative analysis detects dependencies among the 5' splice-site positions. , 2004, RNA.

[85]  E. Androphy,et al.  An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy. , 2004, Biochemical and biophysical research communications.

[86]  S. Stamm,et al.  Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors , 2004, Journal of neurochemistry.

[87]  S. Cawley,et al.  Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. , 2004, Genome research.

[88]  C. Shin,et al.  Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock , 2004, Nature.

[89]  S. Brenner,et al.  An unappreciated role for RNA surveillance , 2004, Genome Biology.

[90]  J. Lucas,et al.  Glycogen Synthase Kinase-3 Plays a Crucial Role in Tau Exon 10 Splicing and Intranuclear Distribution of SC35 , 2004, Journal of Biological Chemistry.

[91]  Sherif Abou Elela,et al.  Reprogramming Alternative Pre-messenger RNA Splicing through the Use of Protein-binding Antisense Oligonucleotides* , 2003, Journal of Biological Chemistry.

[92]  D. Black.  Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[93]  K. K. Yong,et al.  Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome , 2003, Nature Genetics.

[94]  F. Natacci,et al.  NF1 exon 7 skipping and sequence alterations in exonic splice enhancers (ESEs) in a neurofibromatosis 1 patient , 2003, Human Genetics.

[95]  J. Manley,et al.  A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy , 2003, Nature Genetics.

[96]  E. Oláh,et al.  Emerging roles of BRCA1 alternative splicing , 2003, Molecular pathology : MP.

[97]  S. Stamm,et al.  Mutations in Tau Gene Exon 10 Associated with FTDP-17 Alter the Activity of an Exonic Splicing Enhancer to Interact with Tra2β* , 2003, Journal of Biological Chemistry.

[98]  Noam Shomron,et al.  The Birth of an Alternatively Spliced Exon: 3' Splice-Site Selection in Alu Exons , 2003, Science.

[99]  S. Hanks,et al.  Genomic analysis of the eukaryotic protein kinase superfamily: a perspective , 2003, Genome Biology.

[100]  M. Laule,et al.  Interaction of CA repeat polymorphism of the endothelial nitric oxide synthase and hyperhomocysteinemia in acute coronary syndromes: evidence of gender-specific differences , 2003, Journal of Molecular Medicine.

[101]  F. Muntoni,et al.  Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[102]  T. Cooper,et al.  Pre-mRNA splicing and human disease. , 2003, Genes & development.

[103]  A. Krainer,et al.  Correction of disease-associated exon skipping by synthetic exon-specific activators , 2003, Nature Structural Biology.

[104]  Dong Wang,et al.  Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential , 2003, Oncogene.

[105]  Stefan Stamm,et al.  Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. , 2002, Human molecular genetics.

[106]  A. Hunter,et al.  A novel aberrant splice site mutation in the APC gene , 2002, Journal of medical genetics.

[107]  Dan Graur,et al.  Alu-containing exons are alternatively spliced. , 2002, Genome research.

[108]  J. Knezetic,et al.  A hMLH1 genomic mutation and associated novel mRNA defects in a hereditary non-polyposis colorectal cancer family. , 2002, Mutation research.

[109]  Y. Hannun,et al.  De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma Cells , 2002, The Journal of Biological Chemistry.

[110]  A. Krainer,et al.  Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1 , 2002, Nature Genetics.

[111]  H. Grabsch,et al.  Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression , 2002, British Journal of Cancer.

[112]  B. Kerem,et al.  Splicing regulation as a potential genetic modifier. , 2002, Trends in genetics : TIG.

[113]  J. Bergthórsson,et al.  High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer. , 2002, European journal of cancer.

[114]  J. Cuzick,et al.  Abnormal FHIT expression profiles in cervical intraepithelial neoplastic (CIN) lesions , 2002, British Journal of Cancer.

[115]  T. Wienker,et al.  Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. , 2002, American journal of human genetics.

[116]  R. Lothe,et al.  Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis. , 2002, Cancer research.

[117]  J. Valcárcel,et al.  Molecular mechanisms of gene expression regulation by the apoptosis-promoting protein TIA-1 , 2001, Apoptosis.

[118]  Y. Takeshima,et al.  Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient , 2001, Brain and Development.

[119]  T. Misteli,et al.  Correction of Alternative Splicing of Tau in Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17* , 2001, The Journal of Biological Chemistry.

[120]  A. Wellstein,et al.  An Isoform of the Coactivator AIB1 That Increases Hormone and Growth Factor Sensitivity Is Overexpressed in Breast Cancer* , 2001, The Journal of Biological Chemistry.

[121]  J. Manley,et al.  Splicing-related catalysis by protein-free snRNAs , 2001, Nature.

[122]  J. Koh,et al.  Characterization of aberrant FHIT transcripts in gastric adenocarcinomas , 2001, Experimental & Molecular Medicine.

[123]  D. Hunt,et al.  A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). , 2001, Molecular cell.

[124]  I Knudsen,et al.  Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. , 2001, American journal of human genetics.

[125]  X. Estivill,et al.  Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations , 2001, Human Genetics.

[126]  T. Dörk,et al.  Nuclear factor TDP‐43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping , 2001, The EMBO journal.

[127]  C Maayan,et al.  Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. , 2001, American journal of human genetics.

[128]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[129]  C. Mann,et al.  Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[130]  P. Jordan,et al.  Pathological exon skipping in an HNPCC proband with MLH1 splice acceptor site mutation , 2000, Genes, chromosomes & cancer.

[131]  R Kole,et al.  Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[132]  S. Stamm,et al.  Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[133]  J. Valcárcel,et al.  Alternative pre-mRNA splicing: the logic of combinatorial control. , 2000, Trends in biochemical sciences.

[134]  U. Monani,et al.  The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. , 2000, Human molecular genetics.

[135]  M. Knowles,et al.  Correction of Aberrant Splicing of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene by Antisense Oligonucleotides* , 1999, The Journal of Biological Chemistry.

[136]  A. de la Chapelle,et al.  Missense and nonsense mutations in codon 659 of MLH1 cause aberrant splicing of messenger RNA in HNPCC kindreds , 1999, Genes, chromosomes & cancer.

[137]  F. Kittrell,et al.  Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis , 1999, Oncogene.

[138]  G. Schellenberg,et al.  Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[139]  Francisco E. Baralle,et al.  Regulation of Fibronectin EDA Exon Alternative Splicing: Possible Role of RNA Secondary Structure for Enhancer Display , 1999, Molecular and Cellular Biology.

[140]  G. Schellenberg,et al.  A distinct familial presenile dementia with a novel missense mutation in the tau gene. , 1999, Neuroreport.

[141]  C. Duijn,et al.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. , 1999, American journal of human genetics.

[142]  T. Tabira,et al.  FTDP‐17 mutations N279K and S305N in tau produce increased splicing of exon 10 , 1999, FEBS letters.

[143]  R. Vervoort,et al.  A mutation (IVS8+0.6kbdelTC) creating a new donor splice site activates a cryptic exon in an Alu-element in intron 8 of the human β-glucuronidase gene , 1998, Human Genetics.

[144]  C. Ghigna,et al.  Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. , 1998, Cancer research.

[145]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[146]  E. Lyon,et al.  Implications of a novel cryptic splice site in the BRCA1 gene. , 1998, American journal of medical genetics.

[147]  D. Geschwind,et al.  Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[148]  M. Goedert,et al.  Tau protein pathology in neurodegenerative diseases , 1998, Trends in Neurosciences.

[149]  S. Leung,et al.  Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon. , 1998, Human pathology.

[150]  P. Riegman,et al.  A G-->A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofibromatosis 2. , 1998, Human molecular genetics.

[151]  M. Garcia-Blanco,et al.  Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro. , 1997, RNA.

[152]  T. Cooper,et al.  The regulation of splice-site selection, and its role in human disease. , 1997, American journal of human genetics.

[153]  S. Fuqua,et al.  A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion , 1997, Breast Cancer Research and Treatment.

[154]  J. Manley,et al.  Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. , 1997, Genes & development.

[155]  P. Comoglio,et al.  A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype , 1996, Molecular and cellular biology.

[156]  S. Bala,et al.  Multiple products in the protein truncation test due to alternative splicing in the adenomatous polyposis coli (APC) gene , 1996, Human Genetics.

[157]  T. Maniatis,et al.  Assembly of specific SR protein complexes on distinct regulatory elements of the Drosophila doublesex splicing enhancer. , 1996, Genes & development.

[158]  H. Kurahashi,et al.  Biallelic inactivation of the APC gene in hepatoblastoma. , 1995, Cancer research.

[159]  W. Samowitz,et al.  Alternatively spliced adenomatous polyposis coli (APC) gene transcripts that delete exons mutated in attenuated APC. , 1995, Cancer research.

[160]  B. Bapat,et al.  Evidence for a novel exon in the coding region of the adenomatous polyposis coli (APC) gene. , 1995, Genomics.

[161]  D Harrich,et al.  Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs , 1995, Journal of virology.

[162]  C. Antignac,et al.  Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. , 1995, Human molecular genetics.

[163]  J. Weissenbach,et al.  Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.

[164]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[165]  A. Lamond,et al.  Protein phosphatase 1 can modulate alternative 5′ splice site selection in a HeLa splicing extract , 1994, FEBS letters.

[166]  R. Hynes,et al.  Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element. , 1994, Genes & development.

[167]  F. Baralle,et al.  A role for exon sequences in alternative splicing of the human fibronectin gene. , 1987, Nucleic acids research.

[168]  S. Godfrey,et al.  Incidence of familial dysautonomia in Israel 1977–1981 , 1987, Clinical genetics.

[169]  J. Pearn.  CLASSIFICATION OF SPINAL MUSCULAR ATROPHIES , 1980, The Lancet.

[170]  Rudi van Drunen,et al.  Localization of Random Pulse Point Sources Using Physically Implementable Search Algorithms , 2020, Optoelectronics, Instrumentation and Data Processing.

[171]  S. Stamm,et al.  Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing. , 2008, Human molecular genetics.

[172]  E. Buratti,et al.  Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. , 2008, Frontiers in bioscience : a journal and virtual library.

[173]  James P. Orengo,et al.  Alternative splicing in disease. , 2007, Advances in experimental medicine and biology.

[174]  M. Blaustein,et al.  Signals, pathways and splicing regulation. , 2007, The international journal of biochemistry & cell biology.

[175]  J. Gallant,et al.  RNA-Mediated Neuromuscular Disorders , 2007 .

[176]  A. Andreadis.  Misregulation of tau alternative splicing in neurodegeneration and dementia. , 2006, Progress in molecular and subcellular biology.

[177]  N. Lévy,et al.  Altered splicing in prelamin A-associated premature aging phenotypes. , 2006, Progress in molecular and subcellular biology.

[178]  Elisa de Stanchina,et al.  Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2. , 2006, American journal of human genetics.

[179]  B. Wirth,et al.  Spinal muscular atrophy and therapeutic prospects. , 2006, Progress in molecular and subcellular biology.

[180]  P. Jeanteur.  Alternative Splicing and Disease , 2006 .

[181]  U. Francke,et al.  Lack of Pwcr1/MBII-85 snoRNA is critical for neonatal lethality in Prader–Willi syndrome mouse models , 2005, Mammalian Genome.

[182]  D. Neklason,et al.  Intron 4 Mutation in APC Gene Results in Splice Defect and Attenuated FAP Phenotype , 2004, Familial Cancer.

[183]  T. Klimkait,et al.  Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A. , 2004, Nucleic acids research.

[184]  M. Bollen,et al.  Functional diversity of protein phosphatase-1, a cellular economizer and reset button. , 2004, Physiological reviews.

[185]  E. Androphy,et al.  The regulation and regulatory activities of alternative splicing of the SMN gene. , 2004, Critical reviews in eukaryotic gene expression.

[186]  B. Sullenger,et al.  Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing , 2003 .

[187]  K. Woo,et al.  Aberrant splicing of FHIT transcripts in human gastric cancer cell lines. , 2002, Research communications in molecular pathology and pharmacology.

[188]  Michael Q. Zhang,et al.  A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes , 2001, Nature Genetics.

[189]  International Human Genome Sequencing Consortium.  Initial sequencing and analysis of the human genome , 2001, Nature.

[190]  N. Eberhardt,et al.  FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance. , 2000, Clinical endocrinology.

[191]  R. Vervoort,et al.  A mutation (IVS8+0.6kbdelTC) creating a new donor splice site activates a cryptic exon in an , 1998 .

[192]  Bonnie F. Sloane,et al.  Cathepsin B: multiple enzyme forms from a single gene and their relation to cancer. , 1996, Enzyme & protein.